Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 1

Conditions

Neoplasms 4Anxiety Disorders 4Breast Neoplasms 3Motor Activity 2Depression 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Prostatic Neoplasms 1Pain 1Ovarian Neoplasms 1Muscle Weakness 1Multiple Endocrine Neoplasia Type 1 1Head and Neck Neoplasms 1Fatigue 1Cancer Pain 1

Interventions

Exercise 126Resistance Training 15Surveys and Questionnaires 13Walking 11Methods 7High-Intensity Interval Training 7Exercise Therapy 5Diet 5methyl hydroxyethyl cellulose 4Motivational Interviewing 4Standard of Care 3Preoperative Exercise 3Nutritional Status 3Nutrition Assessment 3Cognitive Behavioral Therapy 3Behavior Therapy 3Yoga 2Wearable Electronic Devices 2Waiting Lists 2Therapeutics 2Telerehabilitation 2Self-Management 2Physical Therapy Modalities 2Observation 2Metformin 2Fitness Trackers 2Exercise Test 2Educational Status 2Diet, Mediterranean 2Counseling 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Motor Activity × Autogenic Training × Clear all
NCT02873559 2024-05-29

PROGRESS

University Hospital, Gentofte, Copenhagen

Phase 2/3 Completed
192 enrolled
Endocrine

Motor Activity, Multiple Endocrine Neoplasia Type 1, Muscle Weakness

NCT00740038 2017-02-23

Support for People Undergoing Chemotherapy

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
471 enrolled

Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡